0001213900-20-042291.txt : 20201211
0001213900-20-042291.hdr.sgml : 20201211
20201211170539
ACCESSION NUMBER: 0001213900-20-042291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201211
DATE AS OF CHANGE: 20201211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Straube Richard
CENTRAL INDEX KEY: 0001595197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 201384287
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE, SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2020-12-10
0
0000812796
SOLIGENIX, INC.
SNGX
0001595197
Straube Richard
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
0
1
0
0
CMO
Option (Right to Buy)
2.34
2020-12-10
4
A
0
40000
0
A
2020-12-10
2030-12-09
Common Stock
40000
40000
D
The stock option vested immediately as to 10,000 shares and vests as to the remainder at a rate of 2,500 of the shares on each three (3) month anniversary of December 10,2020.
/s/ Richard Straube
2020-12-11